Status:
COMPLETED
GLP-1 Response in Women With PCOS and Prediabetes
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Incretin Hormones in PCOS With Prediabetes
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Women with PCOS are more prone to obesity which exacerbates insulin resistance, the abdominal fat disposition and metabolic risk of these patients. With development of obesity these women have high co...
Eligibility Criteria
Inclusion
- 18 years old to menopause
- polycystic ovary sindrome (NICHD criteria)
- BMI of 30 kg/m2 or higher
Exclusion
- type 1 or type 2 diabetes mellitus
- Cushing's syndrome or congenital (non-classic) adrenal hyperplasia
- personal or family history of MEN 2
- the use of medications known or suspected to affect reproductive or metabolic functions
- the use of statins within 90 days prior to study entery
Key Trial Info
Start Date :
February 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 27 2017
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03325569
Start Date
February 13 2017
End Date
March 27 2017
Last Update
October 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMC Ljubljana
Ljubljana, Slovenia, 1000